Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1

O Coqueret1, H Gascan

  • 1INSERM E-9928, 4 Rue Larrey, CHU Angers, 49033 Angers Cedex, France. oliver.coqueret@univ-angers.fr

Insights

The cyclin-dependent kinase inhibitor p21, also known as p21(WAF1/CIP1/SDI1), inhibits STAT3 transcriptional activation by interacting with STAT3 and the CREB-binding protein. This reveals a novel inhibitory role for p21 in STAT3 signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Signal transducers and activators of transcription (STAT) factors regulate gene expression following cytokine stimulation.
  • STAT protein activation involves phosphorylation, dimerization, nuclear translocation, and target gene activation, followed by transient down-regulation.

Purpose of the Study:

  • To investigate the role of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/SDI1) in STAT3 transcriptional activation.
  • To elucidate the mechanism by which p21(WAF1/CIP1/SDI1) might regulate STAT3 signaling.

Main Methods:

  • Coimmunoprecipitation and pull-down assays to detect protein-protein interactions.
  • In vivo overexpression studies to assess the effect of p21(WAF1/CIP1/SDI1) on STAT3 transcriptional activity.
  • Analysis of STAT3 DNA binding activity.

Main Results:

  • p21(WAF1/CIP1/SDI1) associates with STAT3 proteins.
  • Overexpression of p21(WAF1/CIP1/SDI1) inhibits STAT3 transcriptional activation without affecting STAT3 DNA binding.
  • p21(WAF1/CIP1/SDI1) interacts with CREB-binding protein, and its inhibitory effect on STAT3 is blocked by CREB-binding protein overexpression.

Conclusions:

  • p21(WAF1/CIP1/SDI1) acts as an inhibitor of STAT3 transcriptional activation.
  • The inhibitory mechanism involves interaction with STAT3 and modulation of the CREB-binding protein coactivator.
  • This study identifies a novel function for p21(WAF1/CIP1/SDI1) as a regulator of STAT signaling.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...